Idorsia Pharmaceuticals Ltd.
Clinical trials sponsored by Idorsia Pharmaceuticals Ltd., explained in plain language.
A biopharmaceutical company focused on discovering and developing small-molecule drugs for various diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill aims to bring back color to vitiligo skin Results expected Jun 2027 (estimated)